Approval · Notice of Compliance 28895 · 2022
OSPHENA: Notice of Compliance 28895
Issued September 2, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28895
- Date
- September 2, 2022
- Company
- Duchesnay Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new drug substance manufacturing and testing site.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OSPHENA | Not yet assigned | — |
Medicinal ingredients
- OSPEMIFENE 60 MG per TAB